⌘K

Home/Filings/4/0001104659-22-080206

4//SEC Filing

Griffiths Graham 4

Accession 0001104659-22-080206

CIK 0001828185other

View on SEC.gov Company Profile

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 4:05 PM ET

Size

18.8 KB

Accession

0001104659-22-080206

Insider Transaction Report

Form 4

Period: 2022-06-23

Vaccitech plcVACC

Griffiths Graham

Chief Business Officer

Transactions

Exercise/Conversion
Ordinary Shares
2022-06-23$0.00/sh+3,090$1→ 123,237 total
Exercise/Conversion
Share Option (Right to Buy)
2022-06-23−1,931→ 0 total
Exercise: $0.00Exp: 2028-02-16→ Ordinary Shares (1,931 underlying)
Exercise/Conversion
Share Option (Right to Buy)
2022-06-23−2,317→ 2,317 total
Exercise: $0.00Exp: 2029-08-14→ Ordinary Shares (2,317 underlying)
Exercise/Conversion
Share Option (Right to Buy)
2022-06-23−3,090→ 6,180 total
Exercise: $0.00Exp: 2030-01-08→ Ordinary Shares (3,090 underlying)
Exercise/Conversion
Ordinary Shares
2022-06-23$0.00/sh+1,931$1→ 117,830 total
Exercise/Conversion
Ordinary Shares
2022-06-23$0.00/sh+2,317$1→ 120,147 total
Sale
Ordinary Shares
2022-06-23$5.28/sh−8$42→ 123,229 total
Small Acquisition
Ordinary Shares
2022-06-24$5.87/sh+100$587→ 123,329 total

Footnotes (5)

[F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
[F2]These shares were sold to cover the exercise price of options exercised by the Reporting Person.
[F3]This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
[F4]This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
[F5]This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.

Documents

1 file

4
tm2221185-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Vaccitech plc

CIK 0001828185

Entity typeother

Related Parties

1

filerCIK 0001851630

Filing Metadata

Form type: 4
Filed: Jul 14, 8:00 PM ET
Accepted: Jul 15, 4:05 PM ET
Size: 18.8 KB

View on SEC.gov